Citadel Advisors
GMVD

Citadel Advisors’s G Medical Innovations Holdings Ltd. Ordinary Shares GMVD Stock Holding History

Citadel Advisors’s Portfolio GMVD Stock Details GMVD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-723
Closed -$15K – 13984
2022
Q2 		$15K Sell
723
-711
-50% -$22.4K ﹤0.01% 12504
2022
Q1 		$64K Buy
+1,434
New +$140K ﹤0.01% 12641

Other funds holding GMVD

S
swisspartners Vaduz, Liechtenstein $78.4M AUM 9.82% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Citadel Advisors's GMVD Position: Q3 2022 in Review

Citadel Advisors sold out of G Medical Innovations Holdings Ltd. Ordinary Shares (GMVD) in Q3 2022, closing a stake of 723 shares — an estimated $15K sold.

Citadel Advisors first reported a position in GMVD in Q1 2022 and held it in 2 quarters. The position peaked at $64K in Q1 2022. 14 funds tracked by Wall St. Rank hold GMVD as of Q3 2022.

  • Citadel Advisors reported no remaining G Medical Innovations Holdings Ltd. Ordinary Shares position as of Q3 2022 after selling out during the quarter.
  • Citadel Advisors sold 723 G Medical Innovations Holdings Ltd. Ordinary Shares shares in Q3 2022, an estimated $15K.
  • Citadel Advisors first reported a position in G Medical Innovations Holdings Ltd. Ordinary Shares in Q1 2022 and held it in 2 quarters.
  • Citadel Advisors's G Medical Innovations Holdings Ltd. Ordinary Shares position peaked at $64K in Q1 2022.
  • 14 funds tracked by Wall St. Rank held G Medical Innovations Holdings Ltd. Ordinary Shares as of Q3 2022.

Based on Citadel Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.